NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

“So you can start to see, even if we get part of the way towards 15,000 a year (in the Sawston facility alone), that is an enormous amount of patients, especially for personalized cell therapies. My understanding is, for example, big company, the big companies who bought the CAR T cell technologies, in their first years of commercial operations, made 50 patient products. Right? So, you know, having the eventual capacity to make up to 15,000 patients would be absolutely enormous.” — Linda Powers, June 29, 2024